P3 Health Partners (NASDAQ:PIII - Get Free Report) had its target price decreased by Lake Street Capital from $50.00 to $20.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has a "buy" rating on the stock. Lake Street Capital's price objective would suggest a potential upside of 123.71% from the stock's previous close.
P3 Health Partners Trading Down 5.9 %
Shares of P3 Health Partners stock traded down $0.56 during trading hours on Monday, reaching $8.94. The stock had a trading volume of 7,348 shares, compared to its average volume of 20,392. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 1.11. P3 Health Partners has a 1 year low of $7.00 and a 1 year high of $40.50. The firm has a market capitalization of $64.21 million, a price-to-earnings ratio of -10.64 and a beta of 0.96. The firm has a 50 day simple moving average of $9.07 and a two-hundred day simple moving average of $11.62.
P3 Health Partners (NASDAQ:PIII - Get Free Report) last issued its earnings results on Thursday, March 27th. The company reported ($16.00) earnings per share for the quarter, missing the consensus estimate of ($8.50) by ($7.50). The company had revenue of $370.69 million during the quarter, compared to analysts' expectations of $378.88 million. P3 Health Partners had a negative return on equity of 71.31% and a negative net margin of 6.95%. As a group, equities research analysts anticipate that P3 Health Partners will post -0.67 earnings per share for the current year.
Hedge Funds Weigh In On P3 Health Partners
A number of large investors have recently bought and sold shares of the business. Geode Capital Management LLC boosted its stake in P3 Health Partners by 115.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,029,259 shares of the company's stock valued at $398,000 after purchasing an additional 550,925 shares during the period. Trinity Financial Advisors LLC acquired a new stake in shares of P3 Health Partners in the fourth quarter worth $261,000. Sanders Morris Harris LLC grew its holdings in shares of P3 Health Partners by 50.0% during the fourth quarter. Sanders Morris Harris LLC now owns 184,497 shares of the company's stock valued at $41,000 after buying an additional 61,499 shares in the last quarter. Abundance Wealth Counselors increased its holdings in shares of P3 Health Partners by 77.3% in the 1st quarter. Abundance Wealth Counselors now owns 400,000 shares of the company's stock valued at $66,000 after purchasing an additional 174,395 shares during the period. Finally, Wealthedge Investment Advisors LLC purchased a new stake in P3 Health Partners in the 4th quarter worth approximately $83,000. Institutional investors own 7.75% of the company's stock.
P3 Health Partners Company Profile
(
Get Free Report)
P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.
Featured Stories
Before you consider P3 Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and P3 Health Partners wasn't on the list.
While P3 Health Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
